Research Article
Beneficial Effects of Ursodeoxycholic Acid on Metabolic Parameters and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind, Placebo-Controlled Clinical Study
Table 1
(a) Patients’ sociodemographic characteristics at baseline of UDCA or placebo treatment. (b) Patients’ clinical characteristics (anthropometry and blood pressure) at baseline and after eight weeks of UDCA or placebo treatment.
(a) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
All values are expressed as or (%). aIndependent sample -test. bMann–Whitney test. cPearson’s chi-square test. DM: diabetes mellitus. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(b) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
All values are expressed as . : Independent sample -test compared with UDCA group. †: Wilcoxon’s signed ranks test compared 8 weeks and baseline in the UDCA group or compared 8 weeks and baseline in the placebo group. F0: beginning of study; F1: end of study; WC: waist circumference; BP: blood pressure. |